Assignee
PROTIVA BIOTHERAPEUTICS INC
CA·25 granted patents·29 pending applications·3,308 citations·filing 1999–2017
Top patents by PatentIndex Score
54 records- 0199US9074208B2Modified siRNA molecules and uses thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Jul 7, 2015·94 cites·44 claims
- 0299US7915399B2Modified siRNA molecules and uses thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2007·Granted Mar 29, 2011·148 cites·11 claims
- 0399US7799565B2Lipid encapsulated interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Sep 21, 2010·367 cites·26 claims
- 0499US7745651B2Cationic lipids and methods of usePROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Jun 29, 2010·368 cites·4 claims
- 0598US9878042B2Lipid formulations for delivery of therapeutic agents to solid tumorsPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Jan 30, 2018·23 cites·18 claims
- 0698US9518272B2Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Granted Dec 13, 2016·116 cites·22 claims
- 0798US9504651B2Lipid compositions for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 29, 2016·144 cites·14 claims
- 0898US9492386B2Liposomal apparatus and manufacturing methodsPROTIVA BIOTHERAPEUTICS INC·Filed 2012·Granted Nov 15, 2016·72 cites·20 claims
- 0998US9404127B2Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Aug 2, 2016·131 cites·22 claims
- 1098US9364435B2Lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Jun 14, 2016·194 cites·20 claims
- 1198US9018187B2Cationic lipids and methods for the delivery of therapeutic agentsPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Apr 28, 2015·116 cites·33 claims
- 1298US8999950B2Compositions and methods for silencing aldehyde dehydrogenasePROTIVA BIOTHERAPEUTICS INC·Filed 2012·Granted Apr 7, 2015·102 cites·35 claims
- 1398US8822668B2Lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted Sep 2, 2014·99 cites·23 claims
- 1498US7982027B2Lipid encapsulated interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2006·Granted Jul 19, 2011·228 cites·63 claims
- 1598US7901708B2Liposomal apparatus and manufacturing methodsPROTIVA BIOTHERAPEUTICS INC·Filed 2003·Granted Mar 8, 2011·344 cites·22 claims
- 1698US7803397B2Polyethyleneglycol-modified lipid compounds and uses thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2004·Granted Sep 28, 2010·313 cites·15 claims
- 1797US9352042B2Trialkyl cationic lipids and methods of use thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Granted May 31, 2016·121 cites·21 claims
- 1897US9187748B2Compositions and methods for silencing ebola virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 17, 2015·93 cites·23 claims
- 1997US7807815B2Compositions comprising immunostimulatory siRNA molecules and DLinDMA or DLenDMAPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Granted Oct 5, 2010·68 cites·28 claims
- 2096US9428751B2Compositions and methods for silencing apolipoprotein C-III expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Aug 30, 2016·80 cites·15 claims
- 2194US9926560B2Lipid encapsulating interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Mar 27, 2018·6 cites·14 claims
- 2286US9035039B2Compositions and methods for silencing SMAD4PROTIVA BIOTHERAPEUTICS INC·Filed 2012·Granted May 19, 2015·12 cites·37 claims
- 2377US6410328B1Sensitizing cells to compounds using lipid-mediated gene and compound deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 1999·Granted Jun 25, 2002·55 cites·22 claims
- 2472US2018071397A1Novel lipid formulations for delivery of therapeutic agents to solid tumorsPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2569US2017258719A1Liposomal apparatus and manufacturing methodsPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2668US2018092848A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2767US2017260523A1Non-liposomal systems for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2867US2018085312A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2963US2016151284A1Compositions and methods for delivering messenger rnaPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3063US2017042814A1Novel lipid formulations for nucleic acid deliveryPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3159US2014288146A1Novel trialkyl cationic lipids and methods of use thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3257US2016256567A1Compositions and methods for delivering messenger rnaPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3357US2016256568A1Compositions and methods for delivering messenger rnaPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3456US6841537B1Combination therapy using nucleic acids and conventional drugsPROTIVA BIOTHERAPEUTICS INC·Filed 1999·Granted Jan 11, 2005·14 cites·29 claims
- 3556US2007054873A1Glucocorticoid modulation of nucleic acid-mediated immune stimulationPROTIVA BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3655US2016264971A1Compositions and methods for silencing ebola virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3755US2005064595A1Lipid encapsulated interfering RNAPROTIVA BIOTHERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3854US2005118253A1Systemic delivery of serum stable plasmid lipid particles for cancer therapyPROTIVA BIOTHERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 3951US2006134189A1siRNA silencing of apolipoprotein BPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 4050US2017151333A1Novel cationic lipids and methods of use thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4150US2011224418A1MODIFIED sIRNA MOLECULES AND USES THEREOFPROTIVA BIOTHERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 4249US2018245077A1Compositions and methods for treating hypertriglyceridemiaPROTIVA BIOTHERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4348US2003077829A1Lipid-based formulationsPROTIVA BIOTHERAPEUTICS INC·Filed 2002·Application pending·0 cites
- 4448US2011189300A1siRNA SILENCING OF APOLIPOPROTEIN BPROTIVA BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 4547US2008171716A1Nucleic acid modulation of toll-like receptor-mediated immune stimulationPROTIVA BIOTHERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 4647US2011177131A1siRNA SILENCING OF FILOVIRUS GENE EXPRESSIONPROTIVA BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 4747US2007218122A1siRNA silencing of influenza virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4845US9765333B2Compositions and methods for silencing marburg virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Granted Sep 19, 2017·0 cites·21 claims
- 4945US2006051405A1Compositions for the delivery of therapeutic agents and uses thereofPROTIVA BIOTHERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 5044US2011262527A1Cationic lipids and methods of usePROTIVA BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PROTIVA BIOTHERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →